Page 694 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

672 PART IV Specific Malignancies in the Small Animal Patient

56. Koblik PD, LeCouteur RA, Higgins RJ, et al.: CT-guided brain 80. Kent MS, Bommarito D, Feldman E, et al.: Survival, neurologic
biopsy using a modified Pelorus Mark III stereotactic system: expe- response, and prognostic factors in dogs with pituitary masses
rience with 50 dogs, Vet Radiol Ultrasound 40:434–440, 1999. treated with radiation therapy and untreated dogs, J Vet Intern Med
VetBooks.ir 57. Moissonnier P, Blot S, Devauchelle P, et al.: Stereotactic CT- 81. Dolera M, Malfassi, Bianchi C, et al.: Frameless stereotactic radio-
21:1027–1033, 2007.
guided brain biopsy in the dog, J Small Anim Pract 43:115–123,
2002.
canine gliomas, Vet Comp Oncol 16:90–101, 2018.
58. Rossmeisl JH, Andriani RA, Cecere TE, et al.: Frame-based stereo- therapy alone and combined with temozolamide for presumed
tactic biopsy of canine brain masses: technique and clinical results 82. Jeffrey N, Brearley MJ: Brain tumors in the dog: Treatment of 10
in 26 cases, Front Vet Sci 2:20, 2015. cases and review of recent literature, J Small Anim Pract 34:367–
59. Barnhart KF, Wojcieszyn J, Storts RW: Immunohistochemical 372, 1993.
staining patterns of canine meningiomas and correlation with pub- 83. Jung DI, Kim HJ, Park C, et al.: Long-term chemotherapy with
lished immunophenotypes, Vet Pathol 39:311–321, 2002. lomustine of intracranial meningioma occurring in a miniature
60. Ide T, Uchida K, Kikuta F, et al.: Immunohistochemical character- schnauzer, J Vet Med Sci 68:383–386, 2006.
ization of canine neuroepithelial tumors, Vet Pathol 47:741–750, 84. Bentley RT, Thomovsky SA, Miller MA, et al. Canine (pet dog)
2010. tumor microsurgery and intratumoral concentration and safety of
61. Lipsitz D, Higgins RJ, Kortz GD, et al.: Glioblastoma multiforme: metronomic chlorambucil for spontaneous glioma: a phase I clini-
clinical findings, magnetic resonance imaging, and pathology in cal trial. World Neurosurg e-pub ahead of print 5/19/18; https://
five dogs, Vet Pathol 40:659–669, 2003. doi:10.1016/j.wneu.2018.05.027 2018.
62. Stoica G, Kim HT, Hall DG, et al.: Morphology, immunohisto- 85. Rossmeisl Jr JH, Garcia PA, Daniel GB, et al.: Invited review-
chemistry, and genetic alterations in dog astrocytomas, Vet Pathol neuroimaging response assessment criteria for brain tumors in vet-
41:10–19, 2004. erinary patients, Vet Radiol Ultrasound 55:115–132, 2014.
63. Stoica G, Levine J, Wolff J, Murphy K: Canine astrocytic tumors: a 86. Chow KE, Tyrell D, Long SN: Early post-operative magnetic reso-
comparative review, Vet Pathol 48:266–275, 2011. nance imaging findings in five dogs with confirmed and suspected
64. Sloma EA, Creneti CT, Erb HN, et al.: Characterization of inflam- brain tumors, Vet Radiol Ultrasound 56:531–539, 2015.
matory changes associated with canine oligodendroglioma, J Comp 87. Gordon LE, Thacher C, Matthiesen DT, et al.: Results of crani-
Pathol 153:92–100, 2015. otomy for the treatment of cerebral meningioma in 42 cats, Vet
65. Dicksinson PJ, Keel MK, Higgins RJ, et al.: Clinical and pathologi- Surg 23:94–100, 1994.
cal features of oligodendrogliomas in two cats, Vet Pathol 37:16– 88. Gallagher JG, Berg J, Knowles KE, et al.: Prognosis after surgical
167, 2000. excision of cerebral meningiomas in cats: 17 cases (1986–1992), J
66. Rissi DR, Miller AD: Feline glioma: A retrospective study and Am Vet Med Assoc 203:1437–1440, 1993.
review of the literature, J Fel Med Surg 19:1307–1314, 2017. 89. Bryant KJ, Steinberg H, McAnulty JF: Cranioplasty by means of
67. Debinski W, Dickinson P, Rossmeisl JH, et al.: New agents for tar- molded polymethylmethacrylate prosthetic reconstruction after
geting of IL-13RA2 expressed in primary human and canine brain radical excision of neoplasms of the skull in two dogs, J Am Vet Med
tumors, PLoS One 8:e77719, 2013. Assoc 223:67–72, 2003.
68. Courtay-Cahen C, Platt SR, De Risio L, et al.: Preliminary analysis 90. Klopp LS, Rao S: Endoscopic-assisted intracranial tumor removal
of genomic abnormalities in canine meningiomas, Vet Comp Oncol in dogs and cats: long-term outcome of 39 cases, J Vet Intern Med
6:182–192, 2008. 23:108–115, 2009.
69. Thomas R, Duke SE, Wang HJ, et al.: ‘Putting our heads together’: 91. Kostolich M, Dulisch ML: A surgical approach to the canine olfac-
insights into genomic conservation between human and canine tory bulb for meningioma removal, Vet Surg 16:273277, 1987.
intracranial tumors, J Neurooncol 94:333–349, 2009. 92. Axlund TW, McGlasson ML, Smith AN: Surgery alone or in
70. Boudreau CE, York D, Higgins RJ, et al.: Molecular signaling path- combination with radiation therapy for treatment of intra-cranial
ways in canine gliomas, Vet Comp Oncol e15:133–150, 2017. meningiomas in dogs: 31 cases (1989–2002), J Am Vet Med Assoc
71. York D, Higgins RJ, LeCouteur RA, et al.: TP53 mutations in 221:1597–1600, 2002.
canine brain tumors, Vet Pathol 49:796–801, 2012. 93. Andersen BM, Pluhar E, Seiler C, et al.: Vaccination for invasive
72. Ancona D, York D, Higgins RJ, et al.: Comparative cytogenetic anal- canine meningioma induces in situ production of antibodies capa-
ysis of dog and human choroid plexus tumors defines sytenic regions ble of antibody dependent cell-mediated cytotoxicity, Cancer Res
of genomic loss, J Neuropathol Exp Neurol 77:413–419, 2018. 73:2987–2997, 2013.
73. Thomson SA, Kennerly E, Olby N, et al.: Microarray analysis of 94. Greco JJ, Aiken SA, Berg JM, et al.: Evaluation of intracranial
differentially expressed genes of primary tumors in the canine cen- meningioma resection with a surgical aspirator in dogs: 17 cases
tral nervous system, Vet Pathol 42:550–558, 2005. (1996–2004), J Am Vet Med Assoc 229:394–400, 2006.
74. Dickinson PJ, Surace EI, Cambell M, et al.: Expression of the 95. Theon AP, Lecouteur RA, Carr EA, et al.: Influence of tumor cell
tumor suppressor genes NF2, 4.1B, and TSLC1 in canine menin- proliferation and sex-hormone receptors on effectiveness of radia-
giomas, Vet Pathol 46:884–892, 2009. tion therapy for dogs with incompletely resected meningiomas, J
75. Bailey CS, Higgins RJ: Characteristics of cisternal cerebrospinal Am Vet Med Assoc 216:701–707, 2000.
fluid associated with primary brain tumors in the dog: a retrospec- 96. Keyerleber MA, McEntee MC, Farrely J, et al.: Three-dimensional
tive study, J Am Vet Med Assoc 188:414–417, 1986. conformal radiation therapy alone or in combination with surgery
76. Dickinson PJ, Sturges BK, Kass PH, et al.: Characteristics of cister- for treatment of canine intracranial meningiomas, Vet Comp Oncol
nal cerebrospinal fluid associated with intracranial meningiomas in 13:385–397, 2015.
dogs: 56 cases (1985-2004), J Am Med Vet Assoc 15:564–567, 2006. 97. Maclellan JD, Arnold SA, Dave AC, et al.: Association of magnetic
77. Palus V, Volk HA, Lamb CR, et al.: MRI features of CNS lym- resonance imaging-based preoperative tumor volume with postsur-
phoma in dogs and cats, Vet Radiol Ultrasound 53:44–49, 2012. gical survival time in dogs with primary intracranial glioma, J Am
78. Hu H, Barker A, Harcourt-Brown T, et al.: Systematic review of Vet Med Assoc 252:98–102, 2018.
brain tumor treatment in dogs, J Vet Intern Med 29:1456–1463, 98. Nakano Y, Nakata K, Shibata S, et al.: Fluorescein sodium-guided
2015. resection of intracranial lesions in 22 dogs, Vet Surg 47:302–309,
79. Van Meervenne S, Verhoeven PS, de Vos J, et al.: Comparison 2018.
between symptomatic treatment and lomustine supplementation 99. Mariani CL, Jennings MK, Olby NJ, et al.: Histiocytic sarcoma
in 71 dogs with intracranial, space-occupying lesions, Vet Comp with central nervous system involvement in dogs; 19 cases (2006-
Oncol 12:67–77, 2014. 2012), J Vet Intern Med 29:607–613, 2015.